Ulla Hedner (Former)
21 – 40 of 57
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
History of rFVIIa therapy.
(
- Contribution to journal › Article
- 2009
-
Mark
Bio-Distribution of Recombinant Factor VIIa: A Possible Explanation for the Hemostatic Effect of rFVIIa in Prophylaxis
(
- Contribution to journal › Published meeting abstract
-
Mark
Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia
(
- Contribution to journal › Letter
-
Mark
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic
(
- Contribution to journal › Article
- 2008
-
Mark
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
(
- Contribution to journal › Article
-
Mark
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?
(
- Contribution to journal › Article
-
Mark
Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
(
- Contribution to journal › Article
-
Mark
Tissue Factor and Factor VIIa as Therapeutic Targets in Disorders of Hemostasis.
(
- Contribution to journal › Scientific review
-
Mark
FactorVIIa and its potential therapeutic use in bleeding-associated pathologies
(
- Contribution to journal › Article
- 2007
-
Mark
Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent
(
- Contribution to journal › Scientific review
-
Mark
Recombinant factor VIIa: its background, development and clinical use.
(
- Contribution to journal › Article
- 2006
-
Mark
Mechanism of action, development and clinical experience of recombinant FVIIa.
(
- Contribution to journal › Article
-
Mark
Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Mechanism of action of factor VIIa in the treatment of coagulopathies.
(
- Contribution to journal › Article
-
Mark
Mechanism of action of recombinant activated factor VII: An update
(
- Contribution to journal › Article
- 2005
-
Mark
The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia
(
- Contribution to journal › Article
- 2004
-
Mark
Recombinant FVIIa.
(
- Contribution to journal › Article
- 2003
-
Mark
The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX
(
- Contribution to journal › Article
-
Mark
Potential role of recombinant factor VIIa as a hemostatic agent.
(
- Contribution to journal › Article
- 2002
-
Mark
The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
(
- Contribution to journal › Article